Is Neuronetics Inc (STIM) overvalued? · rev $74.9M
Neuronetics Inc (STIM) is a medical devices company listed on NASDAQ.
This page asks whether Neuronetics Inc (STIM) looks expensive on cached numbers — not a short thesis.
Latest reported STIM revenue for 2024-12-31 was $74.9M. Net income was -$43.7M. Revenue was up 5.0% from 2023-12-31 to 2024-12-31. STIM currently screens at market cap $84.2M.
STIM currently screens at market cap $84.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next STIM 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the STIM stock page for the full model, not this heading.
Not investment advice.